Olabola Awosika is a Dermatology physician affiliated with Hamzavi Dermatology. OpenAlex indexes 43 publications with 547 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
37605 Pembroke Ave
Livonia, MI 481521050
Telephone
834-591-7931Provider last certified this registry record 15 Nov 2021.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202515 payments
- Janssen Biotech, Inc.Program year202522 payments
- Organon LLCProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
27%Azole Antifungal12.8%Ketoconazole100%Part D≥61 patientsNitroimidazole Antimicrobial5.1%Metronidazole100%Part D≥29 patients+ 2 more classes in this area
Dermatology
23.3%Corticosteroid15.3%Triamcinolone Acetonide92%Fluocinolone Acetonide9%Part D<11 patientsOther antifungals for topical use4.1%Ciclopirox100%Part D≥16 patients+ 2 more classes in this area
Sensory organs
21.4%Corticosteroid21.4%Hydrocortisone49%Clobetasol Propionate42%Betamethasone Dipropionate9%Part D≥74 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of nurse-led education intervention on nurse's knowledge of post-operative management of pain in selected hospitals in Ondo State, Nigeria
Research Journal of Health Sciences
2025 - Trends in sessions in diversity at the American Academy of Dermatology Annual Meetings: 2013–2019
International Journal of Women’s Dermatology
2021 - Reply to “Local recurrence of clinically observed basal cell carcinomas following complete saucerization or punch removal with negative margins: Retrospective case series from 2010 to 2020”
Journal of the American Academy of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”